CN Patent

CN109280076B — 肽酰胺类化合物及其制备方法和在医药上的用途

Assigned to Tibet Haisike Pharmaceutical Co ltd · Expires 2022-04-05 · 4y expired

What this patent protects

本发明涉及一种通式(I)所示的化合物或其立体异构体、水合物、代谢产物、溶剂化物、药学上可接受的盐或共晶及其组合物、制备方法和在医药上的用途，通式(I)如下所示： 各取代基的定义与说明书中一致。

USPTO Abstract

本发明涉及一种通式(I)所示的化合物或其立体异构体、水合物、代谢产物、溶剂化物、药学上可接受的盐或共晶及其组合物、制备方法和在医药上的用途，通式(I)如下所示： 各取代基的定义与说明书中一致。

Drugs covered by this patent

Patent Metadata

Patent number
CN109280076B
Jurisdiction
CN
Classification
—
Expires
2022-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Tibet Haisike Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.